Semantic activation in Parkinson's disease patients on and off levodopa

被引:38
|
作者
Angwin, Anthony J. [1 ]
Arnott, Wendy L.
Copland, David A.
Haire, Miriam P. L.
Murdoch, Bruce E.
Silburn, Peter A. [2 ]
Chenery, Helen J.
机构
[1] Univ Queensland, Div Speech Pathol, Ctr Res Language Proc & Linguist, Brisbane, Qld 4072, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia
基金
澳大利亚研究理事会;
关键词
Dopamine; Language; Parkinson's disease; Semantic priming; Spreading activation; AUTOMATIC SPREADING ACTIVATION; DOPAMINERGIC MODULATION; SENTENCE COMPREHENSION; HEALTHY-INDIVIDUALS; LEXICAL DECISION; VERBAL FLUENCY; BASAL GANGLIA; INHIBITION; TIME; IMPAIRMENT;
D O I
10.1016/j.cortex.2009.02.012
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Research suggests that dopamine may exert a neuromodulatory influence on automatic spreading activation within semantic networks. In order to investigate the influence of dopamine depletion on semantic activation in Parkinson's disease (PD), nine patients with PD performed a lexical decision task when on and off levodopa medication. Eleven healthy controls matched to the PD patients in terms of sex, age and education also participated in the study. Both directly related word pairs (e.g., tiger - stripe) and indirectly related word pairs (word pairs related via a mediating word, e.g., chalk - black) were used to measure semantic activation across stimulus onset asynchronies (SOAs) of 270 msec, 520 msec and 1020 msec. Analysis of variance statistics revealed that the activation of directly related and indirectly related targets was slower for the PD group relative to the control group. Within group comparisons revealed further changes to semantic activation in PD patients off medication, with no activation of directly or indirectly related target words evident in PD patients off medication. These results further clarify the nature of dopamine's neuromodulatory influence on semantic activation, and suggest that the nature of altered semantic activation in PD may depend on the magnitude of dopamine depletion. (C) 2009 Elsevier Srl. All rights reserved.
引用
收藏
页码:950 / 959
页数:10
相关论文
共 50 条
  • [1] Pain Intensity On and Off Levodopa in Patients with Parkinson's Disease
    Nebe, Angelika
    Ebersbach, Georg
    [J]. MOVEMENT DISORDERS, 2009, 24 (08) : 1233 - 1237
  • [2] Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease
    Simoes, Rita Moiron
    Castro Caldas, Ana
    Ferreira, Joaquim J.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (02) : 85 - 101
  • [3] Semantic disturbance for verbs in Parkinson's disease patients off medication
    Herrera, Elena
    Cuetos, Fernando
    [J]. JOURNAL OF NEUROLINGUISTICS, 2013, 26 (06) : 737 - 744
  • [4] A levodopa dry powder inhaler for the treatment of Parkinson's disease patients in off periods
    Luinstra, Marianne
    Grasmeijer, Floris
    Hagedoorn, Paul
    Moes, Jan Reindert
    Frijlink, Henderik W.
    de Boer, Anne H.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 97 : 22 - 29
  • [5] Is there addiction to levodopa in patients with Parkinson's disease?
    Merims, D
    Galili-Mosberg, R
    Melamed, E
    [J]. MOVEMENT DISORDERS, 2000, 15 (05) : 1014 - 1016
  • [6] A novel levodopa dry powder inhaler for treatment of off periods in Parkinson's disease patients
    Luinstra, M.
    Grasmeijer, F.
    Hagedoorn, P.
    Frijlink, H. W.
    de Boer, A. H.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S427 - S427
  • [7] The effect of levodopa on posture in patients with Parkinson's disease
    Benninger, F.
    Khlebtovsky, A.
    Melamed, E.
    Djaldetti, R.
    [J]. MOVEMENT DISORDERS, 2013, 28 : S147 - S147
  • [8] Levodopa effect in painful patients with Parkinson's disease
    Brefel-Courbon, C.
    Payoux, P.
    Ory, F.
    Thalamas, C.
    Rascal, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 56 - 56
  • [9] Levodopa psychosis in patients with idiopathic Parkinson's disease
    García-Escrig, M
    Pareja, FB
    Ponsatí, JTF
    [J]. MEDICINA CLINICA, 1999, 112 (07): : 245 - 250
  • [10] Mortality in Parkinson's disease patients treated with levodopa
    Morgan, JC
    Currie, LJ
    Bennett, JP
    Harrison, MB
    Trugman, JM
    Wooten, GF
    [J]. NEUROLOGY, 2002, 58 (07) : A109 - A109